Van Der Baan, Frederieke H. External Author


Sort by

Selected publications

  • No clinical utility of KRAS variant rs61764370 for ovarian or breast cancerGynecologic Oncology. 2016 Review GET IT
    Times cited: 8
  • Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriersCancer Epidemiology Biomarkers and Prevention2015 Academic Article GET IT
    Times cited: 14